Cosmo Technologies Limited

Irlande


 
Quantité totale PI 120
Rang # Quantité totale PI 10 955
Note d'activité PI 2,6/5.0    54
Rang # Activité PI 13 499
Parent COSMO Pharmaceuticals N.V.
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

37 17
12 9
17 4
24
 
Dernier brevet 2025 - Rifamycin composition for treati...
Premier brevet 2001 - Controlled release and taste mas...
Dernière marque 2025 - C
Première marque 2001 - MMX MULTI MATRIX SYSTEM

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 P/S Pharmaceutical and veterinary preparations; Pharmaceutical and veterinary preparations for treatm...
P/S Diagnostic agents, preparations and substances for medical and surgical purposes; diagnostic age...
2024 P/S Contrast media for use with medical equipment or in medical imaging; diagnostic agents and reage...
P/S Pharmaceutical preparations; Medicines for human purposes; Medical reagent; Diagnostic agents, pr...
P/S Diagnostic agents, preparations and substances for medical and surgical purposes; Diagnostic agen...
P/S Pharmaceutical preparations; medicines for human purposes; medical reagent; diagnostic agents, p...
Invention Rifamycin composition for treating sarcopenia. The present disclosure relates to a composition co...
Invention Oral rifamycin sv compositions. Oral pharmaceutical compositions containing rifamycin SV, or a p...
Invention Liquid delivery composition. The invention provides a composition for use as a delivery vehicle ...
Invention 17a-monoesters and 17a,21-diesters of cortexolone for use in the treatment of tumors. The presen...
2023 P/S Computer hardware used for the detection, identification and diagnosis of lesions and other patho...
P/S Pharmaceutical preparations; Diagnostic agents, preparations and substances for medical and surgi...
2022 Invention Oral rifamycin sv compositions. Oral pharmaceutical compositions containing rifamycin SV, or a ph...
Invention Solid oral composition containing dyes for use in endoscopic diagnosis. Herein described are sol...
Invention 17α-monoesters and 17α,21-diesters of cortexolone for use in the treatment of tumors. The present...
Invention An in-situ gelling enema of rifamycin for treating pouchitis and distal ulcerative colitis. The ...
Invention An in-situ gelling enema of rifamycin for treating pouchitis and distal ulcerative colitis. The p...
P/S Pharmaceutical and veterinary preparations for treatment within the fields of gastroenterology, d...
2020 Invention Oral antimicrobial pharmaceutical compositions. The present invention relates to oral pharmaceut...
Invention Controlled release and taste masking oral pharmaceutical composition. Controlled release and tas...
P/S Contrast media for use with medical equipment or in medical imaging; Diagnostic agents and reagen...
2019 Invention Emulsions or microemulsions for use in endoscopic mucosal resectioning and/or endoscopic submucos...
Invention Solid composition for the oral administration of dyes and diagnostic use thereof. The present ap...
Invention Method for treating intestinal diseases presenting at least one inflammatory component. The pres...
Invention 17alpha-monoesters of cortexolone for use in the treatment of tumors. The present invention prov...
Invention Controlled release and taste masking oral pharmaceutical composition. Controlled release and tast...
2018 Invention Controlled release and taste masking oral pharmaceutical compositions. The invention relates to ...
Invention Liquid delivery composition. The invention provides a composition for use as a delivery vehicle c...
Invention Solid delivery composition. The present invention provides an innovative combination of biomater...
Invention Solid delivery composition. The present invention provides an innovative combination of biomateri...
P/S Diagnostic agents, preparations and substances for medical and surgical purposes, namely, the vis...
P/S Pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for use in g...
P/S Enema preparations; enema preparations for rectal administration containing a dye for cleansing; ...
P/S Pharmaceutical preparations for the treatment of travellers' diarrhea, diarrhea, diverticular dis...
2017 Invention Solid oral composition containing dyes. The present invention relates to methods for improving t...
Invention Solid oral composition containing dyes. The present invention relates to methods for improving th...
Invention Cortexolone 17alpha-propionate for use in the treatment of skin wounds and/or atrophic skin disor...
Invention Controlled release and taste masking oral pharmaceutical compositions. The invention relates to t...
2016 P/S Enema preparations; enema preparations for rectal administration containing a dye for cleansing a...
P/S Diagnostic agents, preparations and substances for medical or surgical purposes; Diagnostic agent...
P/S Pharmaceutical preparations for use in gastroenterology, for colon and digestive system health an...
P/S Pharmaceutical preparations; pharmaceutical preparations for use in the endoscopic diagnostic eva...
2015 Invention Cortexolone 17alpha-benzoate for use in the treatment of tumours. The present invention provides ...
Invention 17α,21-diesters of cortexolone for use in the treatment of tumors. The present invention provides...
P/S Pharmaceutical products; dietetic substances adapted for medical use; lactic ferments for pharmac...
2008 P/S Pharmaceutical preparations for the treatment of the gastroenteric apparatus diseases.
2006 P/S Pharmaceutical preparations for the treatment of the gastroenteric diseases
2005 P/S Pharmaceutical and veterinary preparations such as tablets, capsules, sugar-coated pills, granul...
P/S Pharmaceutical and veterinary preparations, namely anti-inflammatories, anti-infectives, antacids...
P/S Pharmaceutical and veterinary preparations such as tablets, capsules, sugar-coated pills, granule...